secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACRO BIOMEDICAL CO., LTD. (ACBM)
CIK:        0001622996
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001640334-25-001486
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns
----------------------------------------------------------------------------

- Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
- Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.
- Ms. Su previously served as VP of cell banking division at BioSpring Co., Ltd. (Jan 2023 - Aug 2025) and VP at BioSeed Co., Ltd. (Aug 2020 - Dec 2022).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/0001640334-25-001486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/acbm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer